Finance

Lists
Why is BLRX down 2,88%?
Dive Deeper
BLRX:NASDAQ
BioLine RX Ltd - ADR
2,36 $
-2,88%
(-0,070) 1D
2,42 $
+2,54% (+0,060)
Pre-market
Closed: 29 қыр., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLRX...
Open
2,41 $
High
2,50 $
Low
2,36 $
Mkt. cap
12,36 млн
Avg. vol.
22,58 мың
Volume
363,00
52-wk high
4,56 $
52-wk low
2,16 $
EPS
-0,49 $
Beta
1,56
Shares outstanding
4,98 млн
No. of employees
22
Open
2,41 $
High
2,50 $
Low
2,36 $
Mkt. cap
12,36 млн
Avg. vol.
22,58 мың
Volume
363,00
52-wk high
4,56 $
52-wk low
2,16 $
EPS
-0,49 $
Beta
1,56
Shares outstanding
4,98 млн
No. of employees
22
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to BLRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BLRX in the last 3 months
Highest
Current 2,36 $
26,00 $ (+1 001,69%)
Average
26,00 $ (+1 001,69%)
Lowest
26,00 $ (+1 001,69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
26,00 $
+1 001,7%
08/31/2026
Justin Walsh
JonesTrading
Buy
Reiterated
12,00 $
+408,5%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
427,00 м.
194,00 м.
477,00 м.
294,00 м.
Cost of goods sold
84,00 мың
40,00 мың
95,00 мың
59,00 мың
Cost of revenue
84,00 мың
40,00 мың
95,00 мың
59,00 мың
Research and development expenses
1,72 млн
2,42 млн
2,53 млн
2,94 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
831,00 м.
1,12 млн
858,00 м.
865,00 м.
Operating expense
2,55 млн
3,54 млн
3,39 млн
3,81 млн
Total operating expenses
2,63 млн
3,58 млн
3,48 млн
3,87 млн
Operating income
-2,21 млн
-3,39 млн
-3,00 млн
-3,57 млн
Other non operating income
1,16 млн
1,10 млн
458,00 м.
-690,00 м.
EBT including unusual items
-977,00 м.
-2,24 млн
-2,59 млн
-4,34 млн
EBT excluding unusual items
-977,00 м.
-2,24 млн
-2,59 млн
-4,34 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-977,00 м.
-1,38 млн
-1,60 млн
-3,03 млн
Net profit margin
-228,81%
-713,92%
-335,64%
-1 029,25%
Earnings per share
-
-
-
-
Interest and investment income
377,00 м.
-
208,00 м.
132,00 м.
Interest expense
-304,00 м.
-288,00 м.
-250,00 м.
-208,00 м.
Net interest expenses
73,00 мың
-288,00 м.
-42,00 мың
-76,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,09 млн
-3,33 млн
-2,92 млн
-3,50 млн
Gain or loss from assets sale
-
25,00 мың
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары